Literature DB >> 20351131

Cancer symptom clusters: old concept but new data.

Jordanka Kirkova1, Declan Walsh, Aynur Aktas, Mellar P Davis.   

Abstract

Individuals with cancer have multiple symptoms, which frequently co-occur. A nonrandom distribution of symptoms suggests a common mechanism. Symptom clusters (SCs) were considered part of various syndromes in the early years of medicine. The SC concept in clinical medicine is old. Symptom clusters were commonly described in the psychology/psychiatry and neurology literature. Symptom cluster may be defined either clinically or statistically. Statistically derived clusters can differ from clinically defined clusters. The clinical importance of statistically derived clusters is unclear. Pain-insomnia-fatigue and pain-depression-fatigue are commonly recognized clinical clusters. Nausea-vomiting and anxiety-depression are also statistically observed clusters. The longitudinal stability of clusters is unknown. Certain SCs, appear to have a greater adverse influence on outcomes (such as performance status and survival) than others. Comorbidities probably influence symptoms at different levels, but their effect on cancer clusters is unknown. Comprehensive symptom assessment is crucial to cluster identification. The potential use of the cluster concept to abbreviate symptom assessment tools needs validation. Symptom cluster can be disease and/or treatment related and may change as individuals undergo antitumor therapies. Polypharmacy in symptom management is frequent but could be minimized if 1 drug could be used to treat cluster symptoms. Symptom cluster appears to vary with the assessment tool, disease stage, symptom domain used to cluster, cluster methodology, and number of symptoms assessed. The validity and reliability of SCs need universally accepted statistical methods, assessment tools, and symptom domains. For now, nausea-vomiting is recognized as a consistent cluster across multiple studies. Pain-depression-fatigue and pain-insomnia-fatigue are also well recognized. Symptom clusters may help in cancer diagnosis, symptom management, and prognostication. However, the cluster method, reliability, and validity need to be established before assessment or treatment guidelines are established. Symptom clusters require further research before becoming part of routine medical symptom assessment and management.

Entities:  

Mesh:

Year:  2010        PMID: 20351131     DOI: 10.1177/1049909110364048

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  27 in total

1.  Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.

Authors:  Mary E Cooley; David F Lobach; Ellis Johns; Barbara Halpenny; Toni-Ann Saunders; Guilherme Del Fiol; Michael S Rabin; Pamela Calarese; Isidore L Berenbaum; Ken Zaner; Kathleen Finn; Donna L Berry; Janet L Abrahm
Journal:  J Pain Symptom Manage       Date:  2013-05-13       Impact factor: 3.612

2.  An update in symptom clusters using the Edmonton Symptom Assessment System in a palliative radiotherapy clinic.

Authors:  Vithusha Ganesh; Liying Zhang; Stephanie Chan; Bo Angela Wan; Leah Drost; May Tsao; Cyril Danjoux; Elizabeth Barnes; Rachel McDonald; Leigha Rowbottom; Pearl Zaki; Ronald Chow; Matthew K Hwang; Carlo DeAngelis; Nicholas Lao; Edward Chow
Journal:  Support Care Cancer       Date:  2017-05-23       Impact factor: 3.603

3.  Evaluation of Prescribing Medications for Terminal Cancer Patients near Death: Essential or Futile.

Authors:  Hye Ran Lee; Seong Yoon Yi; Do Yeun Kim
Journal:  Cancer Res Treat       Date:  2013-09-30       Impact factor: 4.679

Review 4.  Psychosocial issues in cancer pain.

Authors:  Laura S Porter; Francis J Keefe
Journal:  Curr Pain Headache Rep       Date:  2011-08

5.  The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.

Authors:  Andrea L Cheville; Paul J Novotny; Jeffrey A Sloan; Jeffrey R Basford; Jason A Wampfler; Yolanda I Garces; Aminah Jatoi; Ping Yang
Journal:  J Pain Symptom Manage       Date:  2011-03-12       Impact factor: 3.612

6.  Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.

Authors:  Marcia D McNutt; Shuling Liu; Amita Manatunga; Erica B Royster; Charles L Raison; Bobbi J Woolwine; Marina F Demetrashvili; Andrew H Miller; Dominique L Musselman
Journal:  Neuropsychopharmacology       Date:  2012-02-22       Impact factor: 7.853

7.  Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.

Authors:  Andrea C Betts; Caitlin C Murphy; L Aubree Shay; Bijal A Balasubramanian; Christine Markham; Marlyn Allicock
Journal:  J Cancer Surviv       Date:  2022-01-08       Impact factor: 4.442

8.  The perceptions and experiences of osteopathic treatment among cancer patients in palliative care: a qualitative study.

Authors:  Amie Steel; Colombe Tricou; Thomas Monsarrat; Murielle Ruer; Cécile Deslandes; Corinne Sisoix; Marilène Filbet
Journal:  Support Care Cancer       Date:  2018-05-04       Impact factor: 3.603

Review 9.  Expectations of pain and accompanying symptoms during cancer treatment.

Authors:  Nancy L Wells; Victoria Sandlin
Journal:  Curr Pain Headache Rep       Date:  2012-08

10.  Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews.

Authors:  Charles C Horn; Séverine Henry; Kelly Meyers; Magnus S Magnusson
Journal:  Front Neurosci       Date:  2011-07-14       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.